Laboratory safety during assisted reproduction in patients with blood-borne viruses

被引:27
作者
Gilling-Smith, C
Emiliani, S
Almeida, P
Liesnard, C
Englert, Y
机构
[1] Chelsea & Westminster Hosp, Assisted Concept Unit, London SW10 9NH, England
[2] Erasme Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, Brussels, Belgium
[3] Free Univ Brussels, Fac Med, Lab Res Human Reprod, B-1050 Brussels, Belgium
[4] Free Univ Brussels, AIDS Reference Lab, B-1070 Brussels, Belgium
关键词
assisted reproduction; hepatitis; HIV; reproduction; safety;
D O I
10.1093/humrep/deh828
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
For couples where one or both partners are infected with human immunodeficiency virus or hepatitis C, the doors to receiving fertility care are opening as a result of better antiviral medication, better long-term prognosis and consequent changes in attitude. In line with this, fertility centres electing to treat couples with blood-borne viral (BBV) infection need to re-examine their policies and procedures to ensure the safety of their staff and both non-infected and infected patients during assisted reproduction treatments. At a time when the European Tissue Directive aims to introduce quality standards for assisted reproduction throughout Europe, we highlight the risks involved when treating patients with known BBV infections and argue that safety cannot be met with any certainty unless samples from such patients are handled within a separate high security laboratory or laboratory area, technically adapted to ensure minimal cross-contamination risk to uninfected gametes and embryos.
引用
收藏
页码:1433 / 1438
页数:6
相关论文
共 59 条
[1]
Viral screening and assisted conception treatment - The Bourn Hall experience [J].
Abusheikha, N ;
Akagbosu, F ;
Marcus, S ;
Lass, A ;
Cousins, C ;
Brinsden, P .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1999, 16 (06) :337-339
[2]
*AM FERT SOC, 1994, FERTIL STERIL, V62, pS1
[3]
*AM SOC REPR MED E, 2002, FERTIL STERIL, V77, P212
[4]
*AM SOC REPR MED P, 2004, FERTIL STERIL, V82, P1754
[5]
RESULTS OF ROUTINE SYPHILITIC AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) SEROLOGY IN INFERTILITY [J].
BALASCH, J ;
PUMAROLA, T ;
FABREGUES, F ;
JOVE, I ;
VANRELL, JA .
HUMAN REPRODUCTION, 1992, 7 (07) :970-972
[6]
Attitudes towards routine human immunodeficiency virus (HIV) screening and fertility treatment in HIV positive patients - a UK survey [J].
Balet, R ;
Lower, AM ;
Wilson, C ;
Anderson, J ;
Grudzinkas, JG .
HUMAN REPRODUCTION, 1998, 13 (04) :1085-1087
[7]
Safety of cryopreservation straws for human gametes or embryos:: a preliminary study with human immunodeficiency virus-1 [J].
Benifla, JL ;
Letur-Konïrsch, H ;
Collin, G ;
Devaux, A ;
Kuttenn, F ;
Madelenat, P ;
Brun-Vezinet, F ;
Feldmann, G .
HUMAN REPRODUCTION, 2000, 15 (10) :2186-2189
[8]
Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology [J].
Bertrand, E ;
Zissis, G ;
Marissens, D ;
Gérard, M ;
Rozenberg, S ;
Barlow, P ;
Delvigne, A .
AIDS, 2004, 18 (05) :823-825
[9]
POSSIBLE NOSOCOMIAL TRANSMISSION OF HIV [J].
BLANK, S ;
SIMONDS, RJ ;
WEISFUSE, I ;
RUDNICK, J ;
CHIASSON, MA ;
THOMAS, P .
LANCET, 1994, 344 (8921) :512-514
[10]
Vaccination against hepatitis B in health care workers [J].
Bonanni, P ;
Bonaccorsi, G .
VACCINE, 2001, 19 (17-19) :2389-2394